← All Can B CORP filings

Can B CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

CANB
Can B CORP
10-Q: Can B Corp. Reports Q3 2024 Results, Shifts Focus to Patent Commercialization Amidst Financial Challenges
Can B Corp. announces its Q3 2024 results, marked by a strategic shift away from hemp operations towards commercializing cannabis patents, while facing significant financial headwinds.
CANB
Can B CORP
10-Q: Can B Corp. Reports Q2 2024 Results, Shifts Focus to Cannabis Patents
Can B Corp. announces its Q2 2024 results and a strategic shift towards commercializing cannabis patents after discontinuing its hemp operations.
CANB
Can B CORP
10-Q/A: Can B Corp. Amends Q1 2024 Report Following Auditor Suspension, Reports Significant Losses
Can B Corp. files an amended Q1 2024 report to incorporate a review by a new auditor after the SEC suspended BF Borgers, revealing a net loss of $6.16 million and the discontinuation of hemp operations.
CANB
Can B CORP
10-Q: Can B Corp. Reports Q1 2024 Results, Grapples with Legal Challenges and Going Concern Doubts
Can B Corp.'s Q1 2024 results reveal a net loss, decreased revenues, and ongoing legal battles, raising substantial doubt about the company's ability to continue as a going concern.